Glimwik PM 2mg/500mg/15mg Tablet
Marketer
Biocube Pharma
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Glimwik PM 2mg/500mg/15mg Tablet
Diabetic patients with type 2 mellitus can benefit from Glyconia PM 2mg/500mg/15mg tablets, a triple-combination medication designed to regulate blood glucose. This medication, used in conjunction with a healthy diet and regular exercise, enhances blood sugar management by promoting efficient insulin utilization. Always adhere to your physician's prescribed dosage and frequency, taking the tablet with food to mitigate gastrointestinal discomfort. Missed doses should be taken promptly unless the next dose is imminent; never double the dose to compensate. Excessive intake may trigger hypoglycemia (low blood sugar). Concurrent use with other antidiabetic drugs, alcohol consumption, or meal skipping raises the risk of hypoglycemia; regular blood glucose monitoring is crucial. Common adverse effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, individuals with kidney, liver, or heart conditions should consult their doctor, as should pregnant or lactating women. Pre-treatment kidney function assessment is standard practice. Limiting alcohol consumption is advised due to the potential for increased side effects.
Primary Ingredients of Glimwik PM 2mg/500mg/15mg Tablet
No text provided. Please provide the text you wish me to rephrase.
Uses of Glimwik PM 2mg/500mg/15mg Tablet
Managing type 2 diabetes
Major Benefits of Glimwik PM 2mg/500mg/15mg Tablet:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the Glimwik PM 2mg/500mg/15mg tablet whole; avoid chewing, crushing, or fracturing it. Consume this medication with food.
Common Side effects of Glimwik PM 2mg/500mg/15mg Tablet:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glimwik PM 2mg/500mg/15mg Tablet:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the entire tablet without chewing, crushing, or fracturing it. Consume Glimwik PM 2mg/500mg/15mg tablets with food.
How Glimwik PM 2mg/500mg/15mg Tablet works:
Glimwik PM 2mg/500mg/15mg tablets combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents—to optimize blood sugar management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release, thus reducing blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, retarding intestinal glucose absorption, and enhancing insulin responsiveness. Finally, pioglitazone, a thiazolidinedione, further improves insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glimwik PM 2mg/500mg/15mg Tablet with alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
Using Glimwik PM 2mg/500mg/15mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Glimwik PM 2mg/500mg/15mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if such symptoms arise.
KidneyCAUTION
Caution is advised when administering Glimwik PM 2mg/500mg/15mg tablets to individuals with impaired kidney function; dosage modification may be necessary. Severe kidney disease contraindicates the use of Glimwik PM 2mg/500mg/15mg tablets. Medical supervision, including regular kidney function assessments, is recommended during treatment.
LiverCAUTION
Patients with hepatic impairment should exercise caution when using Glimwik PM 2mg/500mg/15mg tablets, as dosage modification may be necessary. Consult a physician for guidance. The use of Glimwik PM 2mg/500mg/15mg tablets is contraindicated in individuals with severe liver disease.
What if you forget to take Glimwik PM 2mg/500mg/15mg Tablet :
Should you forget a Glimwik PM 2mg/500mg/15mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.
Facts to Know About Glimwik PM 2mg/500mg/15mg Tablet
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Medication Category | Medication for diabetes |
3,018 People bought this recently